Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iveric Bio Inc (NQ: ISEE )

24.27 -0.09 (-0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,320,079
Open 24.29
Bid (Size) 24.00 (5)
Ask (Size) 24.62 (1)
Prev. Close 24.36
Today's Range 23.98 - 24.52
52wk Range 8.850 - 26.35
Shares Outstanding 104,009,398
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
IVERIC Bio (ISEE) Q4 2022 Earnings Call Transcript
ISEE earnings call for the period ending December 31, 2022. 
Via The Motley Fool

Performance

YTD
+20.63%
+20.63%
1 Month
+18.16%
+18.16%
3 Month
+16.40%
+16.40%
6 Month
+63.77%
+63.77%
1 Year
+60.30%
+60.30%

More News

Read More
IVERIC bio's Geographic Atrophy Candidate Shows Significant Reduction In Disease Progression
Via Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Earnings Scheduled For March 1, 2023
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER Trials
From Iveric Bio
Via Business Wire
Iveric Bio to Present at the Cowen 43rd Annual Health Care Conference
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on Wednesday, March 1, 2023
From IVERIC bio, Inc.
Via Business Wire
Apellis Surges To Four-Month High — Sending Rival Iveric Tumbling — On A First-Ever Approval
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors
From IVERIC bio, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy
From Iveric bio, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.